Prozac (Fluoxetine) Tapering with Mark Leeds, D.O.
Prozac, known generically as fluoxetine, holds a unique place in the history of psychiatric medication. Approved by the FDA in 1987, it was the first blockbuster SSRI — a drug that fundamentally changed how depression and anxiety were treated in the United States and around the world. Because Prozac has been prescribed for nearly four decades, many patients have been taking it for 20 or even 30 years. Some were started on the medication as teenagers and have never known adult life without it. For those who now wish to discontinue fluoxetine, the process requires careful, medically supervised tapering — and that is exactly the kind of care Dr. Leeds provides at his concierge telemedicine practice serving patients throughout Florida.
What Makes Fluoxetine Different from Other SSRIs
Fluoxetine is unique among SSRIs because of its remarkably long half-life. While most SSRIs have half-lives measured in hours, fluoxetine’s half-life ranges from 2 to 6 days. Its active metabolite, norfluoxetine, has an even longer half-life of 4 to 16 days. This means that after a patient takes a dose, the medication and its active byproducts remain in the body for an extended period, creating a slow, gradual decline in blood levels rather than the sharp drop-off seen with shorter-acting SSRIs like paroxetine (Paxil) or sertraline (Zoloft).
In the deprescribing world, fluoxetine’s long half-life is often compared to diazepam’s role among benzodiazepines. Just as diazepam is frequently used as a crossover agent in benzodiazepine tapering because its long half-life smooths out interdose withdrawal, fluoxetine can serve a similar bridging function for SSRI discontinuation. Some deprescribing protocols actually involve switching a patient from a shorter-acting SSRI — such as Lexapro, Zoloft, or Paxil — to Prozac liquid formulation before beginning the taper. The long half-life provides what amounts to a “built-in taper” effect, reducing the moment-to-moment fluctuations in serotonin receptor occupancy that drive withdrawal symptoms.
The Myth That Prozac Is Easy to Stop
Because of this long half-life, there is a widespread misconception — even among prescribing physicians — that Prozac is easy to discontinue. Some doctors advise patients to simply stop taking it, reasoning that the slow natural decline in blood levels will prevent withdrawal. For some patients, particularly those on lower doses for shorter durations, this may work. But for many others, especially those who have taken fluoxetine for years or decades, abrupt discontinuation or overly rapid tapering can still produce significant withdrawal symptoms.
These symptoms can include:
- Brain zaps — the electrical shock sensations that are a hallmark of SSRI withdrawal
- Emotional flooding or blunting — sudden waves of intense emotion or, conversely, a disturbing numbness
- Cognitive fog — difficulty concentrating, memory lapses, and mental sluggishness
- Gastrointestinal disturbances — nausea, diarrhea, cramping, and appetite changes
- Dizziness and balance problems — particularly with head movements
- Insomnia or hypersomnia — disruptions to sleep architecture that can persist for weeks
- Flu-like symptoms — body aches, chills, and fatigue
While these symptoms may be less acutely severe than those associated with shorter-acting SSRIs like Paxil, they can still be debilitating — and their delayed onset (due to the long half-life) can make them harder to recognize as withdrawal. Patients and physicians alike may misattribute these symptoms to a relapse of the underlying condition, leading to unnecessary reinstatement of medication at the original or even higher dose.
Physical Dependence Is Not Addiction
Dr. Leeds emphasizes a critical distinction to every patient: physical dependence on fluoxetine is not addiction. Addiction involves compulsive drug-seeking behavior, escalating doses for euphoric effect, and loss of control. Physical dependence is simply the body’s neurobiological adaptation to the long-term presence of a substance. After months or years of SSRI exposure, the serotonin system recalibrates around the drug’s presence. Removing it too quickly causes a physiological disruption — withdrawal — that has nothing to do with willpower, character, or substance abuse.
This distinction matters because many patients feel shame about their difficulty stopping Prozac, and some encounter dismissive attitudes from healthcare providers who conflate dependence with addiction. The care that Dr. Leeds provides is psychiatric medication deprescribing — a legitimate and growing medical discipline — not addiction treatment.
Hyperbolic Tapering and the Maudsley Approach
The approach Dr. Leeds follows is grounded in the principles laid out in the Maudsley Deprescribing Guidelines, which represent the most evidence-based framework for psychiatric medication discontinuation. Central to this approach is the concept of hyperbolic tapering.
The key insight behind hyperbolic tapering is that the relationship between SSRI dose and serotonin receptor occupancy is not linear — it follows a hyperbolic curve. This means that reducing from 40 mg to 20 mg has a relatively modest effect on receptor occupancy, while reducing from 5 mg to 0 mg has an enormous effect. The final reductions must therefore be proportionally much smaller and slower than the initial ones. Even with fluoxetine’s long half-life providing some natural buffering, the tail end of the taper still requires very small, precisely measured dose reductions.
One significant advantage of fluoxetine tapering is that Prozac is commercially available as a liquid formulation (20 mg per 5 mL). This makes precise dose measurement easier than with many other SSRIs that are only available in tablet or capsule form. For the smallest reductions at the end of a taper, compound pharmacies can prepare even more dilute liquid formulations, allowing reductions as small as fractions of a milligram. Dr. Leeds works closely with compounding pharmacies experienced in preparing these custom formulations to ensure accuracy at every stage of the taper.
Psychiatry’s Failure to Provide an Exit Plan
One of the most troubling aspects of modern psychiatric care is the almost total absence of discontinuation planning. Patients are started on SSRIs like Prozac with little discussion of how long they will need to take the medication, what the discontinuation process looks like, or what support will be available when they decide to stop. Many patients report being told they would need medication “for life” — a claim that is not supported by the evidence for most cases of depression and anxiety.
When patients do express a desire to taper, they are frequently given inadequate guidance: “Just cut your dose in half for a couple of weeks, then stop.” This kind of advice, while well-intentioned, ignores the neurobiology of receptor adaptation and can lead to severe withdrawal that is then misinterpreted as proof the patient “needs” the medication. Dr. Leeds believes that every patient who is prescribed a psychiatric medication deserves a clear, evidence-based exit plan — and for those who were never given one, it is not too late to create one.
What Sets Dr. Leeds’ Practice Apart
Mark Leeds, D.O. brings a unique combination of experience and commitment to this work. As a board member of the Benzodiazepine Information Coalition (BIC) and host of The Rehab Podcast, Dr. Leeds is deeply embedded in the community of clinicians and advocates working to improve outcomes for patients navigating psychiatric medication discontinuation.
The practice model is designed specifically for the demands of safe tapering:
- Weekly hour-long appointments — Tapering is not a five-minute medication check. Dr. Leeds provides extended visits to thoroughly assess symptoms, adjust the taper schedule, and address the psychological dimensions of discontinuation.
- 24/7 text access — Withdrawal symptoms do not follow office hours. Patients can reach Dr. Leeds directly by text at any time for guidance and reassurance.
- Direct physician care — Every appointment is with Dr. Leeds personally. Patients are never handed off to a nurse practitioner or physician assistant for their tapering care.
- Concierge telemedicine throughout Florida — The practice operates via telemedicine, making expert deprescribing care accessible to patients across the entire state without the burden of travel.
The Tapering Timeline for Prozac
Every taper is individualized, but the long half-life of fluoxetine can make the process somewhat more manageable than tapering from shorter-acting SSRIs. The natural buffering effect means that small dose changes produce more gradual shifts in receptor occupancy, giving the brain more time to adapt. However, “more manageable” does not mean “fast.” A careful Prozac taper can still take many months, and for patients on high doses or those who have taken the medication for decades, the process may extend to a year or longer.
Dr. Leeds monitors each patient closely throughout the taper, making adjustments based on symptom response rather than adhering to a rigid predetermined schedule. If a patient experiences significant withdrawal symptoms at any reduction, the taper is paused or the dose is temporarily increased to restabilize before proceeding more slowly. The goal is always a successful, sustainable discontinuation — not speed.
Take the First Step
If you have been taking Prozac and are ready to explore tapering, Dr. Leeds is here to help. Whether you are on fluoxetine itself or are currently taking another SSRI and considering a crossover taper using Prozac’s long half-life as an advantage, the first step is a comprehensive evaluation to develop a personalized plan.
Contact Dr. Leeds today to schedule a consultation and learn how medically supervised, evidence-based deprescribing can help you safely reduce or discontinue your medication.
